Ledger.Open graph →
SEC Form D · Amendment · filed December 30, 2019

EMBERA NEUROTHERAPEUTICS, INC

Offering
$8.3M
Sold
$6.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SUDBURY, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

John B. Beaird · Sudbury, MADirectorJoseph B. Lovett · Sudbury, MADirectorRobert B. Linke · Sudbury, MAExec · DirectorRoss B. Barrett · Sudbury, MADirectorMichael Borrus · San Francisco, CADirectorRonald R. Spoehel · Arlington, VAExec · DirectorDaniel Carroll · San Francisco, CADirectorKelly Pladson · VANCOUVER, British Columbia, CanadaDirectorJohn R. Pribnow · MINNEAPOLIS, MNDirectorLorelei A. Peterson · MINNEAPOLIS, MNDirectorRoger L. Cornett · MINNEAPOLIS, MNExec · DirectorMichael A. Knapp · Lubbock, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗